ClinicalTrials.gg
RecruitingNCT07170826IMAG'RICUpdated Oct 22, 2026

Evaluation of a Therapeutic Education Program on Self-image in Patients With Chronic Inflammatory Rheumatic Diseases

An observational study in Chronic Inflammatory Rheumatic Diseases, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 22, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 25 studies in Rheumatic Diseases with a site in France — 8 open to participants now, 8 under way, none of them phase 3. Rheumatic Diseases · France.

Planned enrollment
14th of 15
60 · median 397
Started
2026
with 1 other
Observational
15 of 25
5 open now
Registered
24th of 25
by date
Lead sponsor
4 of 25
Assistance Publique - Hôpitaux de Paris

Among the 25 studies in Rheumatic Diseases with a site in France, this one is the 14th largest by planned enrollment of the 15 observational ones that give a count, is one of 2 that started in 2026, is one of 15 observational ones, and was the 24th registered.

Rheumatic Diseases

264 studies on the registry are indexed under Rheumatic Diseases; 60 are open to participants now.

Browse Rheumatic Diseases studies →

Open to participants now

8 of the 25 studies in Rheumatic Diseases with a site in France are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 41 Rheumatic Diseases studies recruiting now, 18 (44%) set no upper age limit and 12 (29%) stop at 75 or younger; 7 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 25 studies in Rheumatic Diseases with a site in France, or all of them as a file.
02

Study summary

Chronic inflammatory rheumatic diseases (CIRD), like all chronic somatic disease, can impair self-esteem and self-image in affected individuals. Numerous studies conducted in this population have confirmed this fact. Therapeutic patient education (TPE) programs aim to help patients acquire self-care and adaptive skills. However, there is a near-total absence of workshops specifically dedicated to self-image in TPE programs for CIRD. Such educational interventions have shown their effectiveness in contexts such as cancer and obesity. Our study aims to evaluate their effectiveness for patients with CIR.

Read the detailed description

A chronic disease is a long-term, progressive illness that affects the daily life of the person affected. The onset of the disease is a major upheaval, a moment of rupture between a before and an after. Physical functions and appearance can be altered by the disease (deformities, stiffness… in the case of rheumatic diseases) and by treatments.

According to Schilder, body image is "the way our body appears to ourselves." It can be defined as the set of perceptions, emotions, and thoughts related to appearance. It consists of perceptions but also of representations and feelings, which are built and evolve throughout the individual's experience. It is not limited to physical appearance and properties. It is the foundation of identity.

The disease affects the body, but also has an impact on self-perception, self-esteem, and even identity.

The literature highlights the importance of using qualitative research in addition to quantitative methods to grasp the full complexity of body image.

Despite the progress and effectiveness of treatments, recent studies showed that patients with chronic inflammatory rheumatic diseases (CIRD) have an unsatisfactory, disturbed body image. Literature data also reveal that self-esteem and quality of life in this population are lower than in the general population.

Most studies focused on the consequences of the disease, and very few on the actions taken to address these difficulties encountered by patients, even though such actions are recommended.

Therapeutic patient education (TPE) is support offered to the patient and their relatives so they can take ownership of their disease. TPE is a comprehensive approach that meets the patient's needs and aims to maintain and/or improve quality of life with the illness.

Most therapeutic education workshops related to self-image are proposed in the context of cancer, psychiatric disorders, or obesity. Body image is rarely the direct subject of a workshop in programs aimed at patients with CIRD.

A few studies on the impact of image consulting workshops have been conducted in oncology, but very few in the context of other diseases, including rheumatic conditions. Existing studies show an improvement in self-image, self-esteem, and quality of life after educational interventions, thus a real benefit for patients.

03

Conditions studied

  • Chronic Inflammatory Rheumatic Diseases

Browse trials for

Keywords

  • Chronic Inflammatory Rheumatic diseases
  • Therapeutic patient education
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The target population will consist of patients with RIC (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis) participating in the ETP programme

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Suffering from chronic inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis)
  • Having agreed to follow the therapeutic education programme offered by the department as part of routine care
  • Not opposed to participating in the research

Exclusion criteria

Exclusion Criteria:

  • People who do not speak or read French
  • Current pregnancy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Interventions

  • OtherSelf questionnaire

    Rosenberg Scale, SF36, MBRSQ

  • Otherinterview

    Semi-structured individual interviews

06

What researchers measure

Primary outcomes

  1. To evaluate a therapeutic patient education intervention focused on self-image in patients with chronic inflammatory rheumatic diseases

    Multidimensional Body-Self Relations Questionnaire (MBSRQ)

    Time frame: 3 months following completion of the 'self-image' module

Secondary outcomes

  1. To evaluate a therapeutic patient education intervention on each domain of self-image

    Measurement of each subscale of the Multidimensional Body-Self Relations Questionnaire (MBSRQ)

    Time frame: 3 months following completion of the 'self-image' module

  2. To evaluate a therapeutic patient education intervention focused on self-image in relation to self-esteem.

    Rosenberg Self-Esteem Scale before participation : min = 10, max=40

    Time frame: 3 months following completion of the 'self-image' module

  3. To evaluate a therapeutic patient education intervention focused on self-image in relation to quality of life.

    Measurement of the quality of life score using the SF-36 questionnaire

    Time frame: 3 months following completion of the 'self-image' module

  4. To explore body image in patients after participating in therapeutic education workshops on self-image.

    Data from individual qualitative interviews (inductive approach).

    Time frame: 4 months following completion of the 'self-image' module

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Mar 2029, 33 months after the start.

Of 37 observational studies under Rheumatic Diseases, half reached primary completion within 55 months of starting (the median), counting those still running; a quarter within 14. This study's planned 33 months is below that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: start Oct 2025 → Jun 2026, primary completion Jul 2028 → Mar 2029 and completion Oct 2028 → Jun 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 28, 2025
First posted
Sep 12, 2025
StartActual
Jun 12, 2026was Oct 2025
Primary completionEst.
Mar 2029was Jul 2028
CompletionEst.
Jun 2029was Oct 2028
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 22, 2026
Sites
Hôpital Cochin - Service de rhumatologie -27 rue du Faubourg St Jacques is now Recruiting
Oct 22, 2026
Start date
Oct 2025→Jun 12, 2026 (actual)
Oct 22, 2026
Primary completion
Jul 2028→Mar 2029
Oct 22, 2026
Study completion
Oct 2028→Jun 2029
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Not yet recruiting→Recruiting
    Hôpital Cochin - Service de rhumatologie -27 rue du Faubourg St Jacques is now Recruiting
    Start date Oct 2025→Jun 12, 2026 (now actual)
    Primary completion Jul 2028→Mar 2029
    Study completion Oct 2028→Jun 2029
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07170826
Collaborators
URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Sep 12, 2025
Start date
Jun 12, 2026
Primary completion
Mar 2029 (estimated)
Completion
Jun 2029 (estimated)
Last update
Oct 22, 2026

Study contacts

Marie Laure TOURNEUR, Therapeutic education nurse
Contact
marie-laure.tourneur@aphp.fr
01 58 41 26 58 ext. +33
Aline DECHANET, Project advisor
Contact
aline.dechanet@aphp.fr
Marie Laure TOURNEUR, Marie Laure
principal investigator · AP-HP - Hôpital Cochin - Service de rhumatologie.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion